arrow
Y

Yahya Ahmadipour

University Medicine Essen
H指数:15
被引数:674

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Machine learning models for adverse drug reaction prediction. A systematic review and three-level multilevel meta-analysis

机器学习模型用于药物不良反应预测:系统综述和三级多层元分析

2026-09-150
OA
Mental health and suicidality in glioblastoma patients in germany – a multicenter cross-sectional observational study protocol (SHINE-GLIO Study)

德国胶质母细胞瘤患者的心理健康和自杀行为——一项多中心横断面观察性研究方案(SHINE-GLIO研究)

2026-08-060
OAAI
Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF)

新诊断胶质母细胞瘤中肿瘤治疗电场在放疗前和放疗期间的安全性与可行性:PriCoTTF I/II期试验中Arm A可行性队列的结果

2026-07-270
OAAI
Phosphorylated mTOR immunohistochemistry–guided use of temsirolimus in recurrent IDH-wildtype glioblastoma: a real-world retrospective series

磷酸化mTOR免疫组化指导下的替西罗莫司在复发性IDH野生型胶质母细胞瘤中的应用:一项真实世界回顾性系列研究

2026-04-070
OAAI
Calcification of the Internal Carotid Artery and Its Influence on the Severity of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage

颈内动脉钙化及其对动脉瘤性蛛网膜下腔出血脑血管痉挛严重程度的影响

2026-03-040
OAAI
COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy Adults

新型冠状病毒肺炎和流感加强疫苗接种可在与健康成年人相当的原发性脑肿瘤患者中引起强大的抗体反应

Cancers
IF4.4
2026-02-030
OAAI
The role of neurosurgery for brain metastases between 2012 and 2022: Results of the multicenter SUBAROMA study

2012年至2022年间脑转移瘤神经外科治疗的作用:多中心SUBAROMA研究的结果

2026-02-010
PRE
Preoperative HRQoL predicts postoperative olfactory performance in patients undergoing endoscopic transsphenoidal surgery for pituitary adenoma

术前健康相关生活质量预测垂体腺瘤患者经鼻蝶窦内镜手术后的嗅觉功能表现

2025-12-010
OAAI
The impact of home medications on the risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

动脉瘤性蛛网膜下腔出血后,家庭用药对迟发性脑缺血风险的影响

2025-11-260
OAAI
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?

新诊断胶质母细胞瘤患者中骨髓毒性的分布及预后意义:是否应更积极治疗?

2025-11-010
OAAI
Infarct Timing and Predictors of Infarct-Free Survival in Patients with Aneurysmal Subarachnoid Hemorrhage

脑动脉瘤性蛛网膜下腔出血患者中梗死时间与无梗死生存的预测因子

2025-10-010
OAAI
DISTRIBUTION AND PROGNOSTIC SIGNIFICANCE OF MYELOTOXICITY IN NEWLY DIAGNOSED GLIOBLASTOMA IN A REAL-LIFE COHORT: TIME TO TREAT MORE AGGRESSIVELY?

新诊断胶质母细胞瘤真实世界队列中骨髓毒性的分布及预后意义:是时候更积极治疗了吗?

2025-10-010
OAAI
Decoding glioblastoma survival: unraveling the prognostic potential of olfactory function in a prospective observational study

解码胶质母细胞瘤生存:前瞻性观察性研究中嗅觉功能预后潜力的揭示

2025-07-240
OAAI
Surgical treatment of multiple breast cancer brain metastases: clinical characteristics and factors impacting postoperative survival

多发性乳腺癌脑转移的手术治疗:临床特征及影响术后生存的因素

2025-04-290
OA
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma

ATLAS/NOA-29研究方案: 一项新诊断的颞叶胶质母细胞瘤前颞叶切除术与全切除术的III期随机对照试验

2025-02-200
OAAI
THE ROLE OF FIBROBLAST ACTIVATION PROTEIN IN GLIOBLASTOMA AND GLIOSARCOMA - A COMPARISON OF TISSUE, 68GA-FAPI-46 POSITRON EMISSION TOMOGRAPHY AND SURVIVAL DATA
2024-11-110
PRE
THE ROLE OF FIBROBLAST ACTIVATION PROTEIN IN GLIOBLASTOMA AND GLIOSARCOMA - A COMPARISON OF TISSUE, 68GA-FAPI-46 POSITRON EMISSION TOMOGRAPHY AND SURVIVAL DATA
2024-10-170
PRE